Sifting through countless of stocks in the Commercial Services & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Axonex AI Group Limited, Axonex AI Group Limited or Enovis Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.
Read on to learn how Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation compare based on key financial metrics to determine which better meets your investment needs.
About Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation
Axonex AI Group Limited, through its subsidiaries, focuses on artificial intelligence and robotics solutions. It also provides interior design and fit-out work services. The company was formerly known as Mint Incorporation Limited and changed its name to Axonex AI Group Limited in 2026. Axonex AI Group Limited was incorporated in 2018 and is based in Kowloon, Hong Kong.
Axonex AI Group Limited, through its subsidiaries, focuses on artificial intelligence and robotics solutions. It also provides interior design and fit-out work services. The company was formerly known as Mint Incorporation Limited and changed its name to Axonex AI Group Limited in 2026. Axonex AI Group Limited was incorporated in 2018 and is based in Kowloon, Hong Kong.
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.
Latest Commercial Services & Supplies and Axonex AI Group Limited, Axonex AI Group Limited Stock News
As of October 16, 2026, Axonex AI Group Limited had a $7.5 million market capitalization, compared to the Commercial Services & Supplies median of $591.9 million. Axonex AI Group Limited’s stock is down 99.3% in 2026, down 99.3% in the previous five trading days and down 99.34% in the past year.
Currently, Axonex AI Group Limited does not have a price-earnings ratio. Axonex AI Group Limited’s trailing 12-month revenue is $2.3 million with a -450.3% net profit margin. Year-over-year quarterly sales growth most recently was -53.3%. There are no analysts providing consensus earnings estimates for the current fiscal year. Axonex AI Group Limited does not currently pay a dividend.
As of October 16, 2026, Axonex AI Group Limited had a $7.5 million market cap, putting it in the 6th percentile of all stocks. Axonex AI Group Limited’s stock is down 99.3% in 2026, down 99.3% in the previous five trading days and down 99.34% in the past year.
Currently, Axonex AI Group Limited does not have a price-earnings ratio. Axonex AI Group Limited’s trailing 12-month revenue is $2.3 million with a -450.3% net profit margin. Year-over-year quarterly sales growth most recently was -53.3%. There are no analysts providing consensus earnings estimates for the current fiscal year. Axonex AI Group Limited does not currently pay a dividend.
How We Compare Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation Stock Grades
Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation’s stock grades to see how they measure up against one another.
Learn more about A+ Investor here!
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation’s Quality Grades
| Company | Ticker | Quality |
| Axonex AI Group Limited | AXNX | F |
| Axonex AI Group Limited | AXNX | F |
| Enovis Corporation | ENOV | B |
Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.
The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.
The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.
Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.
Axonex AI Group Limited has a Quality Score of 0, which is Very Weak.
Axonex AI Group Limited has a Quality Score of 0, which is Very Weak.
Enovis Corporation has a Quality Score of 67, which is Strong.
The Quality Stock Winner: No Clear Winner
Neither Axonex AI Group Limited, Axonex AI Group Limited or Enovis Corporation has a high enough Quality Grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Axonex AI Group Limited, Axonex AI Group Limited or Enovis Corporation is the better investment when it comes to quality.
Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation’s Momentum Grades
| Company | Ticker | Momentum |
| Axonex AI Group Limited | AXNX | F |
| Axonex AI Group Limited | AXNX | F |
| Enovis Corporation | ENOV | F |
Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.
Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.
Axonex AI Group Limited has a Momentum Score of 2, which is Very Weak.
Axonex AI Group Limited has a Momentum Score of 2, which is Very Weak.
Enovis Corporation has a Momentum Score of 20, which is Very Weak.
The Momentum Stock Winner: No Clear Winner
Neither Axonex AI Group Limited, Axonex AI Group Limited or Enovis Corporation has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Axonex AI Group Limited, Axonex AI Group Limited or Enovis Corporation is the better investment when it comes to momentum.
Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation’s Estimate Revisions Grades
| Company | Ticker | Earnings Estimate |
| Axonex AI Group Limited | AXNX | na |
| Axonex AI Group Limited | AXNX | na |
| Enovis Corporation | ENOV | C |
Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).
Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.
Axonex AI Group Limited does not have a meaningful Earnings Estimate Score.
Axonex AI Group Limited does not have a meaningful Earnings Estimate Score.
Enovis Corporation has a Earnings Estimate Score of 47, which is Neutral.
The Earnings Estimate Revisions Stock Winner: No Clear Winner
Neither Axonex AI Group Limited, Axonex AI Group Limited or Enovis Corporation has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Axonex AI Group Limited, Axonex AI Group Limited or Enovis Corporation is the better investment when it comes to estimate revisions.
Don’t Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions
Other Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation Grades
In addition to Momentum, Estimate Revisions and Quality, A+ Investor also provides grades for Value and Growth.
Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.
Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.
These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation pass any of our 60+ stock screens that have outperformed the market since their creation.
So, Which Is the Better Investment, Axonex AI Group Limited, Axonex AI Group Limited or Enovis Corporation Stock?
Overall, Axonex AI Group Limited stock has a Momentum Score of 2, Estimate Revisions Score of and Quality Score of 0.
Axonex AI Group Limited stock has a Momentum Score of 2, Estimate Revisions Score of and Quality Score of 0.
Enovis Corporation stock has a Momentum Score of 20, Estimate Revisions Score of 47 and Quality Score of 67.
Comparing Axonex AI Group Limited, Axonex AI Group Limited and Enovis Corporation’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.
Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.
A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.
Included With AAII Platinum
Screen: 23.7%
Annual Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.